TransRare is a preeminent translation and interpretation enterprise that specializes in uncommon tongues. Our team of skilled translators and interpreters is conversant in over 160 languages, enabling your company to reach every corner of the globe with assurance.
| Website | http://www.transrare.com |
| Revenue | $13.6 million |
| Employees | 26 (7 on RocketReach) |
| Industry | Translation and Localization |
| Keywords | Translation Services, Interpretation Services, Language Translation, Global Translation, Multilingual Translation, Translator, Interpreter, Language Services, Translation Agency, Linguistic Services, Localization Services, Global Communication, Cross Cultural Communication, International Communication, Language Solutions, Translation Technology, Language Consulting, Translation Management |
| Competitors | Novartis, Bristol Myers Squibb, Gilead Sciences, Vertex Pharmaceuticals, BioMarin Pharmaceutical Inc., Spark Therapeutics, Inc., bluebird bio, uniQure, AVROBIO, Sarepta Therapeutics, Inc. +41 more (view full list) |
Looking for a particular TransRare employee's phone or email?
The TransRare annual revenue was $13.6 million in 2026.
Ehab Mohamed is the Director of Operations of TransRare.
7 people are employed at TransRare.
TransRare is based in Cairo, Cairo Governorate.